There was an error with your search parameters. Please clear your search and try again.
21 to 30 of 141 Results
Adobe PDF - 64.2 KB -
MD5: ad6c63c17fd489fa8c647b90891930e3
Suppl. Fig. 41. Funnel plot with trim-and-fill for trials investigating adrenal insufficiency any grade under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 68.4 KB -
MD5: d78f68109278d4cd9cce0b16cc721242
Suppl. Fig. 45. Funnel plot with trim-and-fill for trials investigating adrenal insufficiency grade3-5 under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 69.0 KB -
MD5: 7a808d3c389b01b8f49293d6bfed88ab
Suppl. Fig. 49. Funnel plot with trim-and-fill for trials investigating insulin-dependent diabetes mellitus any grade under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 63.9 KB -
MD5: a78f4750989043bac256c01eb6e1d727
Suppl. Fig. 53. Funnel plot with trim-and-fill for trials investigating insulin-dependent diabetes mellitus grade3-5 under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 219.1 KB -
MD5: b0d44cc6d4f377511600f93c84adb67c
Suppl. Table 10. Trim-and-fill results for trials investigating adrenal insufficiency grade 3-5 after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 216.4 KB -
MD5: 37c1389d7ef9b12de77e87300a627604
Suppl. Table 11. Trim-and-fill results for trials investigating insulin-dependent diabetes mellitus any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 219.2 KB -
MD5: f9d8e1df71b9731cc42906df4abab368
Suppl. Table 12. Trim-and-fill results for trials investigating insulin-dependent diabetes mellitus grade 3-5 after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 625.1 KB -
MD5: 591d49eda306f69d5fd24a059d714ccc
Suppl. Table 1. Checklist according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monoth... |
Adobe PDF - 363.9 KB -
MD5: 7c1640658f8d06736e3dad712a927841
Suppl. Table 2. Search strategies for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors. |
MS Excel Spreadsheet - 116.7 KB -
MD5: 7b97c14d958dffb9cb3347b48fd10fba
Suppl. Table 3. Study characteristics of randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors. NSCLC, Non-small cell lung cancer; LD-SCLC, Limited... |